Personal tools
You are here: Home The Cancer Letter Archive
Document Actions

The Cancer Letter Archive

Sept. 3, 2010, Vol. 36 No. 31

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal. Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering. FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove. Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research.

Aug. 6, 2010, Vol. 36 No. 30

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type. Lawrence Corey Named President Of Fred Hutchinson Cancer Research Center. NCI Advisors Approve Research Network On Screening. Letter to the Editors: Society of Toxicology Comments On President's Cancer Panel Report.

July 30, 2010, Vol. 36 No. 29

Varmus, Duke Ask IOM To Investigate Potti's Scientific Work, Clinical Trials. Michigan Scientist David Beer Sought Retraction Of Potti's NEJM Paper Over Misuse Of His Data. Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding. Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins.

July 23, 2010, Vol. 36 No. 28

The Potti Scandal: By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure. Duke Officials Decline To Provide Details Of Probe. Biostatisticians Write To Varmus Asking NCI To Investigate. The Lancet Oncology Issues “Expression Of Concern” Over Paper. Duke Insiders Allege Intimidation By Administration. Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin.

July 16, 2010, Vol. 36 No. 27

Prominent Duke Scientist Claimed Prizes He Didn't Win, Including Rhodes Scholarship. New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science.

July 9, 2010, Vol. 36 No. 26

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies. Interview With Departing NCI Director; Advice To His Successor. Center For Health Policy And Outcomes Established At Memorial Sloan Kettering. ONS Marks 35th Year.

July 2, 2010, Vol. 36 No. 25

Three Cooperative Groups To Combine Statistical Center Operations. Former Group Chair Responds To Niederhuber: Change But Don't Dissolve Cooperative Groups. CMS To Begin National Coverage Analysis Of Provenge.

June 25, 2010, Vol. 36 No. 24

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System. Pfizer's Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies.

June 18, 2010, Vol. 36 No. 23

Medicare's 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR. Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer. Ohio State Breaks Ground For $1 Billion Expansion Of Medical Center, Cancer Hospital. Groups Lobby Congress For $5.8 Billion Budget For NCI, Increases For Other Programs.

June 11, 2010, Vol. 36 No. 22

NIH Director: NCI's Special Authorities “More Of A Negative Than A Positive.” ASCO: NCI Authorities Still Important. DeVita: “The War On Cancer Is Dead.”

June 4, 2010, Vol. 36 No. 21

Shaky Start for FY11 Appropriations Cycle as Congress Feels Pressure to Cut Spending. Medicare Cuts Payments To Physicians By 21%. House Bill Would Mandate Medicare Coverage Of CT Scans For Colorectal Cancer Screening. Science Agencies Seek To Measure Effect Of Research Funding. Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program.

May 28, 2010, Vol. 36 No. 20

Dispute At City of Hope Pits Center Against For-Profit Physician Group. Children's Memorial Hospital Receives $3 Million Endowment From Prince Trust.

Log in


Forgot your password?
Google Ad Links
Google Ads
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: